WVCTSI announces 4 fall funding opportunities

The West Virginia Clinical and Translational Science Institute (WVCTSI) has released requests for applications (RFA) for the Open Competition, Launch Pilot Grant, Small Grant, and Open Competition (WVCTSI and WVU Cancer Institute) funding opportunities.

The Open Competition RFA allows applicants to request up to $50,000 in funding which must be utilized over a 12 month period. This funding opportunity seeks to find innovative research that addresses healthcare needs in West Virginia. Examples include, but are not limited to, addiction and resultant emerging epidemics, cancer, cardiovascular disease, chronic lung disease, and neuroscience. 

The Launch Pilot Grant program focuses on accelerating the translation of intellectual property developed by WVCTSI researchers into realized inventions and patents. Applicants can request up to $50,000 in funding, which must be utilized over 9 months.

The Small Grants RFA is an open competition where applicants can request up to $5,000 in funding to address the health care needs of West Virginia. This funding must be utilized over 6 months.

WVCTSI and the WVU Cancer Institute have also partnered to offer an Open Grant Competition RFA for Cancer Research. This collaborative funding opportunity allows applicants to request up to $50,000 that must be utilized over 24 months. Applications must focus on cancer topics, including cancer clinical research, cancer prevention and early detection research, and/or laboratory based cancer research.

For information on Letter of Intent and full proposal deadlines for Fall 2018, visit the WVCTSI funding page.

Applications should follow all stated guidelines and must be submitted via the iLab platform. Detailed instructions on the application process can be found in each individual RFA. Questions about available funding opportunities should be directed to Camille Charlier (ccharlie@hsc.wvu.edu) or Meghan Reeves (mreeves1@hsc.wvu.edu).

WVCTSI will be hosting multiple information sessions for those interested in applying for any of the fall funding opportunities. Dates and locations for sessions can be found below, additional details will be released soon.

  • WVU Health Sciences Center- Room 201 of the Erma Byrd Biomedical Research Building
    • Tuesday, October 16, 9 to 10 a.m.

    • Wednesday, October 17, 4:30 to 5:30 p.m.

  • Marshall University: Thursday, October 25, 4 to 5 p.m.- Cabell Medical Center Orthopedic Classroom
  • Charleston Area Medical Center: Friday, October 26, 12 to 1 p.m.- CHERI Building Conference Room A&B


im 9/26/18



Camille Charlier, West Virginia Clinical and Translational Science Institute

304.293.4275 wvctsi.org 

Other Recent Stories

  • 2018 Cancer Burden Report Released

    WVU Cancer Institute's Cancer Prevention and Control, in collaboration with the West Virginia Cancer Registry, has released the 2018 Cancer Burden Report. The report provides updated statewide, age-adjusted incidence rates and counts for cancer diagnosed among West Virginia residents from 2011 to 2015.

  • WVU Cancer Institute surgical oncologists perform new treatment for abdominal cancer

    Brian Boone, M.D., surgical oncologist in the WVU Medicine Department of Surgery and WVU Cancer Institute, performed the state’s first hyperthermic intraperitoneal chemotherapy (HIPEC) infusion. This treatment delivers heated, sterilized chemotherapy to the abdomen as a treatment for cancer that has spread to the lining of the abdominal cavity, or peritoneum.